The London-based hVIVO and Switzerland-based SGS are two leading clinical research organisations who are pursuing human trials to expedite the vaccine formation. The two companies, along with an array of global advocates backing their cause, called the human trials a necessary to save thousands of lives that would be lost due to delay in vaccine development.